Rankings
▼
Calendar
LXRX Q4 2015 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$693M
Q4 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$127M
Gross Profit
$97M
76.1% margin
Operating Income
$88M
69.4% margin
Net Income
$87M
68.2% margin
EPS (Diluted)
$0.76
Cash Flow
Operating Cash Flow
$266M
Free Cash Flow
$266M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$655M
Total Liabilities
$369M
Stockholders' Equity
$286M
Cash & Equivalents
$521M
← FY 2015
All Quarters
Q1 2016 →
